RBM3 and neoplasm: Analysis of 5-year OS using the trichotomised variable of RBM3 expression (Figure 3c) revealed a significantly reduced survival for patients with RBM3 negative tumours compared to those with high expression (p=0.005) while survival was similar for the intermediate category for RMB3 expression, as also demonstrated using a dichotomised variable comparing negative RBM3 expression with any RBM3 expression (p=0.006, Figure 3d).